George Tetz M.D.

George Tetz, MD, PhD, serves as the Chief Executive Officer at Biotech and Group CEO at CLS Therapeutics and HMI since January 2017. In addition to these roles, George Tetz is the CEO of Frontiers and has been a Topic Editor since June 2020. George Tetz also contributes as an Editorial Board Member for Scientific Reports under Nature Research since November 2018, and serves as a Consultant at TGV-Biomed since 2017. George Tetz holds a Doctor of Philosophy degree in Medicine.